Kyongbo Pharmaceutical Co., Ltd (214390.KS)
214390.KS Stock Price Chart
Explore Kyongbo Pharmaceutical Co., Ltd interactive price chart. Choose custom timeframes to analyze 214390.KS price movements and trends.
214390.KS Company Profile
Discover essential business fundamentals and corporate details for Kyongbo Pharmaceutical Co., Ltd (214390.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Jun 2015
Employees
505.00
Website
https://www.kbpharma.co.krCEO
Tae-Young Kim
Description
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients in South Korea. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also exports its products to 30 countries worldwide. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan, South Korea.
214390.KS Financial Timeline
Browse a chronological timeline of Kyongbo Pharmaceutical Co., Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2025
EPS came in at -₩29.07 , while revenue for the quarter reached ₩60.59B .
Earnings released on 18 Mar 2025
EPS came in at ₩73.27 , while revenue for the quarter reached ₩59.31B .
Dividend declared on 27 Dec 2024
A dividend of ₩50.00 per share was announced, adjusted to ₩50.00. The dividend was paid on 1 Apr 2025.
Earnings released on 14 Nov 2024
EPS came in at ₩45.22 , while revenue for the quarter reached ₩58.23B .
Earnings released on 14 Aug 2024
EPS came in at ₩6.55 , while revenue for the quarter reached ₩58.41B .
Earnings released on 26 Apr 2024
EPS came in at ₩69.01 , while revenue for the quarter reached ₩62.60B .
Earnings released on 29 Jan 2024
EPS came in at ₩85.21 , while revenue for the quarter reached ₩61.27B .
Dividend declared on 27 Dec 2023
A dividend of ₩50.00 per share was announced, adjusted to ₩50.00. The dividend was paid on 23 Apr 2024.
Earnings released on 27 Oct 2023
EPS came in at ₩31.98 , while revenue for the quarter reached ₩54.58B .
Earnings released on 28 Jul 2023
EPS came in at ₩38.17 , while revenue for the quarter reached ₩52.55B .
Earnings released on 28 Apr 2023
EPS came in at -₩30.95 , while revenue for the quarter reached ₩47.95B .
Earnings released on 30 Jan 2023
EPS came in at ₩59.54 , while revenue for the quarter reached ₩57.81B .
Dividend declared on 28 Dec 2022
A dividend of ₩50.00 per share was announced, adjusted to ₩50.00. The dividend was paid on 14 Apr 2023.
Earnings released on 28 Oct 2022
EPS came in at ₩2.00 , while revenue for the quarter reached ₩49.33B .
Earnings released on 30 Jul 2022
EPS came in at -₩43.00 , while revenue for the quarter reached ₩46.11B .
Earnings released on 29 Apr 2022
EPS came in at ₩7.00 , while revenue for the quarter reached ₩43.01B .
Earnings released on 21 Jan 2022
EPS came in at -₩129.11 , while revenue for the quarter reached ₩41.94B .
Dividend declared on 29 Dec 2021
A dividend of ₩50.00 per share was announced, adjusted to ₩50.00. The dividend was paid on 15 Apr 2022.
Earnings released on 29 Oct 2021
EPS came in at -₩190.00 , while revenue for the quarter reached ₩38.96B .
Earnings released on 30 Jul 2021
EPS came in at -₩58.00 , while revenue for the quarter reached ₩46.06B .
Earnings released on 17 May 2021
EPS came in at ₩64.00 , while revenue for the quarter reached ₩43.69B .
Earnings released on 9 Feb 2021
EPS came in at ₩12.04 , while revenue for the quarter reached ₩48.54B .
Dividend declared on 29 Dec 2020
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 16 Apr 2021.
Earnings released on 30 Oct 2020
EPS came in at ₩103.00 , while revenue for the quarter reached ₩54.74B .
214390.KS Stock Performance
Access detailed 214390.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.